Srinivas Akkaraju insider trades: Scholar Rock Holding (SRRK) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Srinivas reports to the SEC
and 25 more companies
Open-market buys and sales
86 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 26, 2026 | SRRK | ↑ Buy | 192,982 | $41.45 | $8.0M | By Samsara Opportunity Fund, L.P. | Oct 27, 2026 (1d) |
| Oct 26, 2026 | SRRK | ↑ Buy | 96,488 | $41.45 | $4.0M | By Samsara BioCapital, L.P. | Oct 27, 2026 (1d) |
| Jan 9, 2026 | ALMS | ↑ Buy | 588,235 | $17.00 | $10.0M | By Samsara Opportunity Fund, L.P. | Jan 13, 2026 (4d) |
| Dec 18, 2025 | KLRS | ↑ Buy | 479,847 | $10.42 | $5.0M | By Samsara Opportunity Fund, L.P. | Feb 17, 2026 (61d) |
| Dec 5, 2025 | ALMS | ↑ Buy | 186,377 | $9.84 | $1.8M | By Samsara Opportunity Fund, L.P. | Dec 9, 2025 (4d) |
| Dec 4, 2025 | ALMS | ↑ Buy | 262,027 | $7.79 | $2.0M | By Samsara Opportunity Fund, L.P. | Dec 4, 2025 (0d) |
| Dec 1, 2025 | ALMS | ↑ Buy | 173,589 | $7.55 | $1.3M | By Samsara Opportunity Fund, L.P. | Dec 1, 2025 (0d) |
| Nov 20, 2025 | ALMS | ↑ Buy | 125,743 | $7.20 | $905K | By Samsara Opportunity Fund, L.P. | Nov 24, 2025 (4d) |
| Nov 19, 2025 | ALMS | ↑ Buy | 241,338 | $6.34 | $1.5M | By Samsara Opportunity Fund, L.P. | Nov 19, 2025 (0d) |
| Nov 13, 2025 | ALMS | ↑ Buy | 276,179 | $5.25 | $1.4M | By Samsara Opportunity Fund, L.P. | Nov 17, 2025 (4d) |
| Oct 7, 2025 | SRRK | ↑ Buy | 29,599 | $39.92 | $1.2M | By Samsara Opportunity Fund, L.P. | Dec 16, 2025 (70d) |
| Oct 6, 2025 | SRRK | ↑ Buy | 500,439 | $37.58 | $18.8M | By Samsara Opportunity Fund, L.P. | Oct 7, 2025 (1d) |
| Sep 4, 2025 | MLYS | ↑ Buy | 588,235 | $25.50 | $15.0M | By Samsara Opportunity Fund, L.P. | Sep 8, 2025 (4d) |
| May 5, 2025 | ALMS | ↑ Buy | 320,290 | $4.61 | $1.5M | By Samsara BioCapital, L.P. | May 6, 2025 (1d) |
| Mar 13, 2025 | MLYS | ↑ Buy | 600,000 | $13.50 | $8.1M | By Samsara BioCapital, L.P. | Mar 17, 2025 (4d) |
| Nov 26, 2024 | NGNE | ↑ Buy | 48,770 | $25.83 | $1.3M | By Samsara BioCapital, L.P. | Nov 27, 2024 (1d) |
| Oct 7, 2024 | SRRK | ↓ Sell | 665,713 | $30.58 | $20.4M | By Samsara BioCapital, L.P. | Oct 7, 2024 (0d) |
| Oct 7, 2024 | SRRK | ↓ Sell | 510,000 | $27.50 | $14.0M | Samsara BioCapital, L.P. | Oct 7, 2024 (0d) |
| May 30, 2024 | CRGX | ↑ Buy | 294,000 | $17.00 | $5.0M | By Samsara BioCapital, L.P. | Jun 3, 2024 (4d) |
| Dec 21, 2023 | SYRS | ↑ Buy | 904,977 | $4.42 | $4.0M | By Samsara BioCapital, L.P. | Dec 26, 2023 (5d) |
| Nov 14, 2023 | CRGX | ↑ Buy | 666,666 | $15.00 | $10.0M | By Samsara BioCapital, L.P. | Nov 16, 2023 (2d) |
| Oct 16, 2023 | SRRK | ↑ Buy | 2,189,781 | $6.85 | $15.0M | By Samsara BioCapital, L.P. | Oct 18, 2023 (2d) |
| Feb 14, 2023 | MLYS | ↑ Buy | 937,500 | $16.00 | $15.0M | Indirect | Feb 16, 2023 (2d) |
| May 27, 2022 | KDNY | ↑ Buy | 570,000 | $14.00 | $8.0M | By Samsara BioCapital, L.P. | Jun 1, 2022 (5d) |
| Apr 12, 2022 | GRPH | ↑ Buy | 424,464 | $4.08 | $1.7M | By Samsara BioCapital, L.P. | Apr 13, 2022 (1d) |
| Jan 24, 2022 | GRPH | ↑ Buy | 123,000 | $8.94 | $1.1M | By Fund | Jan 25, 2022 (1d) |
| Jan 20, 2022 | GRPH | ↑ Buy | 97,670 | $9.10 | $889K | By Fund | Jan 21, 2022 (1d) |
| Dec 15, 2021 | GRPH | ↑ Buy | 22,329 | $10.19 | $228K | By Fund | Dec 20, 2021 (5d) |
| Nov 22, 2021 | GRPH | ↑ Buy | 201,685 | $10.15 | $2.0M | By Fund | Nov 24, 2021 (2d) |
| Nov 15, 2021 | KDNY | ↑ Buy | 1,215,000 | $14.00 | $17.0M | Indirect | Nov 17, 2021 (2d) |
| Oct 15, 2021 | GRPH | ↑ Buy | 50,800 | $13.14 | $668K | By Fund | Oct 15, 2021 (0d) |
| Oct 8, 2021 | GRPH | ↑ Buy | 145,496 | $13.53 | $2.0M | By Fund | Oct 8, 2021 (0d) |
| Aug 18, 2021 | KDNY | ↑ Buy | 208,500 | $11.98 | $2.5M | Indirect | Aug 20, 2021 (2d) |
| Jun 29, 2021 | GRPH | ↑ Buy | 500,000 | $17.00 | $8.5M | By Fund | Jul 1, 2021 (2d) |
| Mar 12, 2021 | ICPT | ↑ Buy | 237,000 | $21.17 | $5.0M | Indirect | Mar 12, 2021 (0d) |
| Aug 18, 2020 | SYRS | ↓ Sell | 159,327 | $13.10 | $2.1M | Indirect | Aug 19, 2020 (1d) |
| Jul 1, 2020 | SYRS | ↓ Sell | 4,627 | $11.01 | $51K | Indirect | Jul 6, 2020 (5d) |
| Jun 25, 2020 | SYRS | ↓ Sell | 154,700 | $11.11 | $1.7M | Indirect | Jun 25, 2020 (0d) |
| May 5, 2020 | SGEN | ↓ Sell | 8,500 | $167.26 | $1.4M | Direct | May 7, 2020 (2d) |
| Dec 2, 2019 | ARAV | ↑ Buy | 133,333 | $7.50 | $1000K | Indirect | Dec 2, 2019 (0d) |
| Nov 21, 2019 | SGEN | ↓ Sell | 17,500 | $119.78 | $2.1M | Direct | Nov 22, 2019 (1d) |
| Aug 28, 2019 | ICPT | ↑ Buy | 5,207 | $60.32 | $314K | Indirect | Aug 30, 2019 (2d) |
| Apr 9, 2019 | SYRS | ↑ Buy | 533,332 | $7.50 | $4.0M | Indirect | Apr 11, 2019 (2d) |
| Feb 19, 2019 | ICPT | ↓ Sell10b5-1 | 23,438 | $128.78 | $3.0M | Indirect | Feb 21, 2019 (2d) |
| Sep 18, 2018 | PRNB | ↑ Buy | 175,000 | $17.00 | $3.0M | Indirect | Sep 20, 2018 (2d) |
| Jun 13, 2018 | VSAR | ↑ Buy | 53,018 | $2.13 | $113K | Indirect | Jun 15, 2018 (2d) |
| Jun 8, 2018 | VSAR | ↑ Buy | 1,055,485 | $1.81 | $1.9M | Indirect | Jun 8, 2018 (0d) |
| Jan 31, 2018 | SYRS | ↑ Buy | 209,424 | $9.55 | $2.0M | Indirect | Feb 2, 2018 (2d) |
| Dec 14, 2017 | SYRS | ↑ Buy | 109,774 | $9.03 | $992K | Indirect | Dec 14, 2017 (0d) |
| Dec 5, 2017 | VSAR | ↑ Buy | 976,467 | $2.17 | $2.1M | Indirect | Dec 5, 2017 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SRRK insiders
Open-market trades in the last 12 months
About Srinivas Akkaraju's insider trades
Srinivas Akkaraju is an insider at Scholar Rock Holding (SRRK). Since Feb 9, 2007, Srinivas has reported 56 open-market purchases worth $256.7M and 30 sales worth $101.3M on SEC Form 4. In the last 12 months: 10 buys ($36.1M).
1 sale (3% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include grants and awards (100 filings), option exercises (26 filings), other transactions (15 filings), conversions (14 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SRRK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.